全文获取类型
收费全文 | 1555篇 |
免费 | 131篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 31篇 |
妇产科学 | 25篇 |
基础医学 | 156篇 |
口腔科学 | 30篇 |
临床医学 | 182篇 |
内科学 | 210篇 |
皮肤病学 | 13篇 |
神经病学 | 139篇 |
特种医学 | 33篇 |
外科学 | 429篇 |
综合类 | 38篇 |
一般理论 | 1篇 |
预防医学 | 136篇 |
眼科学 | 11篇 |
药学 | 163篇 |
中国医学 | 2篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 13篇 |
2022年 | 16篇 |
2021年 | 39篇 |
2020年 | 18篇 |
2019年 | 23篇 |
2018年 | 35篇 |
2017年 | 26篇 |
2016年 | 30篇 |
2015年 | 51篇 |
2014年 | 54篇 |
2013年 | 75篇 |
2012年 | 84篇 |
2011年 | 90篇 |
2010年 | 51篇 |
2009年 | 44篇 |
2008年 | 77篇 |
2007年 | 75篇 |
2006年 | 86篇 |
2005年 | 93篇 |
2004年 | 77篇 |
2003年 | 60篇 |
2002年 | 51篇 |
2001年 | 38篇 |
2000年 | 37篇 |
1999年 | 35篇 |
1998年 | 13篇 |
1997年 | 10篇 |
1996年 | 13篇 |
1995年 | 10篇 |
1993年 | 10篇 |
1992年 | 14篇 |
1991年 | 19篇 |
1990年 | 18篇 |
1989年 | 22篇 |
1988年 | 15篇 |
1987年 | 22篇 |
1986年 | 10篇 |
1984年 | 18篇 |
1983年 | 14篇 |
1982年 | 10篇 |
1979年 | 18篇 |
1976年 | 10篇 |
1974年 | 13篇 |
1973年 | 9篇 |
1972年 | 15篇 |
1971年 | 11篇 |
1970年 | 8篇 |
1969年 | 9篇 |
1968年 | 10篇 |
1966年 | 11篇 |
排序方式: 共有1687条查询结果,搜索用时 15 毫秒
131.
132.
Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas 总被引:2,自引:0,他引:2
Le QT Kong C Lavori PW O'byrne K Erler JT Huang X Chen Y Cao H Tibshirani R Denko N Giaccia AJ Koong AC 《International journal of radiation oncology, biology, physics》2007,69(1):167-175
PURPOSE: To investigate the expression pattern of hypoxia-induced proteins identified as being involved in malignant progression of head-and-neck squamous cell carcinoma (HNSCC) and to determine their relationship to tumor pO(2) and prognosis. METHODS AND MATERIALS: We performed immunohistochemical staining of hypoxia-induced proteins (carbonic anhydrase IX [CA IX], BNIP3L, connective tissue growth factor, osteopontin, ephrin A1, hypoxia inducible gene-2, dihydrofolate reductase, galectin-1, IkappaB kinase beta, and lysyl oxidase) on tumor tissue arrays of 101 HNSCC patients with pretreatment pO(2) measurements. Analysis of variance and Fisher's exact tests were used to evaluate the relationship between marker expression, tumor pO(2), and CA IX staining. Cox proportional hazard model and log-rank tests were used to determine the relationship between markers and prognosis. RESULTS: Osteopontin expression correlated with tumor pO(2) (Eppendorf measurements) (p = 0.04). However, there was a strong correlation between lysyl oxidase, ephrin A1, and galectin-1 and CA IX staining. These markers also predicted for cancer-specific survival and overall survival on univariate analysis. A hypoxia score of 0-5 was assigned to each patient, on the basis of the presence of strong staining for these markers, whereby a higher score signifies increased marker expression. On multivariate analysis, increasing hypoxia score was an independent prognostic factor for cancer-specific survival (p = 0.015) and was borderline significant for overall survival (p = 0.057) when adjusted for other independent predictors of outcomes (hemoglobin and age). CONCLUSIONS: We identified a panel of hypoxia-related tissue markers that correlates with treatment outcomes in HNSCC. Validation of these markers will be needed to determine their utility in identifying patients for hypoxia-targeted therapy. 相似文献
133.
Monica Ravenstijn Gerlof du Bois Ritsert C. Jansen Chang Liu Gregorius P. M. Luyten Redmer van Leeuwen Mor M. Dickman Nic J. Reus Suzanne Yzer Caroline C. W. Klaver 《Ophthalmic & physiological optics》2023,43(3):327-336
Purpose
To understand and compare perspectives of patients and professionals on current ophthalmologic care for high myopia, and to identify challenges and future opportunities.Methods
Self-reported data were collected through two online questionnaires. Patient perspective was obtained from highly myopic members of a patient organisation based in the Netherlands using a 17-item questionnaire consisting of open and multiple-choice questions regarding personal experience with myopia care. The ophthalmologist perspective was obtained from practising Dutch ophthalmologists with a 12-item questionnaire of multiple-choice questions on work-related demographics, myopia care in daily practice and need for improvement. The response rate for patients was 27% (n = 136/500) and for ophthalmologists, 24% (n = 169/716).Results
Patients were highly concerned about personal progressive loss of vision (69%) and feared their psychological well-being (82%) in case this would happen. The quality of performance of care provided by ophthalmologists was rated as excellent or satisfactory by 64% of the patients. These ratings for multidisciplinary care and insurance reimbursement were as low as 28% and 18% respectively. The mean concern among ophthalmologists about the rise in high myopia was 6.9 (SEM 0.1) on a 10-point scale. Sixty-nine per cent of the ophthalmologists reported that asymptomatic myopic patients should not be examined regularly at outpatient clinics. Ophthalmologists urged the development of clinical guidelines (74%), but did report (95%) that they informed patients about risk factors and complications. This contrasted with the view of patients, of whom 42% were discontent with information provided by ophthalmologists.Conclusions
These questionnaires demonstrated that the current clinical care delivered to highly myopic patients is in need of improvement. The expected higher demand for myopia care in the near future requires preferred practice patterns, professionals specifically trained to manage myopic pathology, accurate and comprehensive information exchange and collaboration of in- and out-of-hospital professionals across the full eye care chain. 相似文献134.
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder 总被引:5,自引:0,他引:5
Denys D van Megen HJ van der Wee N Westenberg HG 《The Journal of clinical psychiatry》2004,65(1):37-43
BACKGROUND: The treatment guidelines for obsessive-compulsive disorder (OCD) propose to switch serotonin reuptake inhibitors (SRIs) in case of refractoriness. However, no controlled research has been published yet that prospectively examined the effects of changing SRIs. This article describes the first double-blind switch study of 2 SRIs in patients with OCD. METHOD: 150 patients with primary OCD, according to DSM-IV criteria, were randomly assigned in a 12-week, double-blind trial to receive dosages titrated upward to 300 mg/day of venlafaxine (N = 75) or 60 mg/day of paroxetine (N = 75). Primary efficacy was assessed by the change from baseline on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), and nonresponse was defined as less than 25% reduction on the Y-BOCS. After a 4-week tapering phase, 43 nonresponders were switched to 12 additional weeks of the alternate antidepressant, of which 16 patients received venlafaxine and 27 received paroxetine. RESULTS: Eighteen of 43 patients benefited from a switch to the alternate SRI with a mean +/- SD decrease of at least 25% on the Y-BOCS. At the end of 12 weeks, responder rates were 56% for paroxetine (15/27) and 19% for venlafaxine (3/16). An intent-to-treat, last-observation-carried-forward analysis demonstrated a mean decrease on the Y-BOCS of 1.8 +/- 3.5 in the venlafaxine group and 6.5 +/- 7.1 in the paroxetine group. After 2 consecutive SRI trials, 109 of 150 patients (73%) achieved a Y-BOCS decrease of at least 25%. CONCLUSION: The results of the current study show that 42% of the nonresponders benefited from a crossover to the other SRI, and that paroxetine was more efficacious than venlafaxine in the treatment of nonresponders to a previous SRI trial. Switching SRIs in case of refractoriness may be considered a useful strategy for patients with OCD. 相似文献
135.
136.
137.
Daisuke Nakajima Yui Watanabe Akihiro Ohsumi Mauricio Pipkin Manyin Chen Pierre Mordant Takashi Kanou Tomohito Saito Ryan Lam Rafael Coutinho Lindsay Caldarone Stephen Juvet Tereza Martinu Rohin K. Iyer John E. Davies David M. Hwang Thomas K. Waddell Marcelo Cypel Shaf Keshavjee 《The Journal of heart and lung transplantation》2019,38(11):1214-1223
138.
139.
Using a thyroid disease‐free population to define the reference interval for TSH and free T4 on the Abbott Architect analyser 下载免费PDF全文
140.